Fas and Fas ligand in human hepatocellular carcinoma

Journal of Gastroenterology

Volumn 36, Issue 10, 2001, Pages 727-728

  Takehara, T ^a   Hayashi, N ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; FAS ANTIGEN; FAS LIGAND; PROTEIN BCL 2; TUMOR NECROSIS FACTOR RECEPTOR;

APOPTOSIS; CANCER CELL; CELL DEATH; CELL KILLING; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DISEASE COURSE; EDITORIAL; HUMAN; HUMAN CELL; HYPOTHESIS; IMMUNOCOMPETENT CELL; INTRACELLULAR KILLING; LEUKEMIA CELL; LIVER CELL CARCINOMA; LYMPHOCYTE ACTIVATION; MEDICAL LITERATURE; METASTASIS; MUTATION; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; TARGET CELL;

APOPTOSIS; CARCINOMA, HEPATOCELLULAR; FAS LIGAND PROTEIN; HUMANS; LIVER NEOPLASMS; MEMBRANE GLYCOPROTEINS; MUTATION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034752941     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005350170040     Document Type: Editorial

References (18)

1. Apoptosis by death factor
2. Lethal effect of the anti-Fas antibody in mice
3. Fas antigen expression and its relationship with apoptosis in human hepatocellular carcinoma and noncancerous tissues
4. Expression of Fas and anti-Fas-mediated apoptosis in human hepatocellular carcinoma cell lines
5. Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells: A mechanism of immune evasion?
6. Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53
7. Fas and Fas ligand: Strong co-expression in human hepatocytes surrounding hepatocellular carcinoma; can cancer induce suicide in peritumoral cells?
8. Expression of Fas ligand in liver metastases of human colonic adenocarcinomas
9. Immune privilege or inflammation? Insights into the Fas ligand enigma
10. Countering the "counterattack" hypothesis
11. Expression of Fas/Fas ligand and its involvement in infiltrating lymphocytes in hepatocellular carcinoma (HCC)
12. The status of Fas and Fas ligand expression can predict recurrence of hepatocellular carcinoma
13. The alteration of Fas receptor and ligand system in hepatocellular carcinomas: How do hepatoma cells escape from the host immune surveillance in vivo?
14. The Fas system is not significantly involved in apoptosis in human hepatocellular carcinoma
15. Resistance to Fas-mediated apoptosis in human hepatoma cells
16. Expression of Fas and Fas-related molecules in human hepatocellular carcinoma
17. Expression and role of Bcl-xL in human hepatocellular carcinomas
18. Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis